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Abstract  
Coeliac Disease (CD) is an incurable autoimmune condition managed by a therapeutic 
gluten-free diet for life.  European studies suggest that the chronicity of CD, the 
limitations imposed by the need to follow a permanent restrictive diet and the risk of 
other associated serious diseases can have a negative impact on health-related quality of 
life (HRQoL) and psychological well-being. However, studies concerning the 
psychosocial effects of CD in the UK population are scarce.  This cross-sectional survey 
(N=288) explores the illness perceptions and self-efficacy beliefs of adults with CD in the 
UK and reports their subjective levels of HRQoL and psychological well-being.  Results 
showed that HRQoL and psychological well-being were reduced with levels being 
comparable to those found in previous related studies.  Participants with weak beliefs in 
the serious consequences of CD and reduced emotional reactions to the condition had a 
greater likelihood of having enhanced HRQoL, improved psychological well-being and 
increased self-efficacy.  Strong beliefs in personal control over the condition and a 
greater perceived understanding of CD were also associated with increased self-efficacy.   
The results suggest that perceived self-efficacy and illness perceptions could play an 
important role in informing psychological interventions for individuals with CD.  
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perceptions; Self-efficacy; Health Related Quality of Life. 
 
 
 3 
Introduction 
Coeliac Disease (CD) is a chronic autoimmune disorder in which hypersensitivity to 
gluten causes damage and inflammation to the small intestine in genetically susceptible 
individuals (Fera et al., 2003). Those with an untreated condition experience intestinal 
malabsorption due to partial or total atrophy of the tiny finger like projections (villi) on 
the surface of the small intestine (Jones, 2007). The condition is also associated with 
osteoporosis, and fertility problems in women, type I diabetes (Feighery, 2007) and an 
increased risk of gastrointestinal cancer and non-Hodgkin’s lymphoma (West, Logan, 
Smith et al., 2004).  It is estimated that CD may affect up to 1 in 100 people in Western 
European populations, although many individuals remain undiagnosed (Hopper et al., 
2007).  Diagnosis is usually achieved through a screening blood test followed by a biopsy 
of the small intestine to detect villous atrophy.  CD can occur at any age, but in adults the 
peak incidence is in the fifth decade and females are more commonly affected than males 
(Jones, 2007).  The condition is incurable but is managed by a therapeutic gluten-free-
diet for life.  A gluten-free diet (GFD) involves the complete avoidance of all foods made 
from or containing wheat, rye, barley and usually, oats. This diet is very successful in 
managing the symptoms of CD as the removal of gluten allows the villi to re-generate 
therefore leading to the normal absorption of nutrients and restoration of nutritional 
balance (Häuser et al., 2007). 
Although the literature on the immunology and physiopathology of CD is now 
extensive (Kagnoff, 2005; Barone et al., 2007) the impact of the condition from the 
individual’s view is less well known.  The chronicity of the condition, the limitations 
imposed by the need to follow a permanent restrictive diet and the risk of other associated 
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diseases can have a negative impact on health-related quality of life (HRQoL) (Casellas 
et al., 2008) and psychological well-being (Addolorato et al., 2008). 
It is therefore not surprising that, increasingly the focus of research is turning to the 
psychosocial impact of CD on those with the condition and their families (Fera et al., 
2003; Hallert, Sandlund & Broqvist, 2003).  Much of this research is concerned with 
psychological well-being and health related quality of life (HRQoL).  For example, 
European studies suggest that depression and lower quality of life affect individuals with 
CD, and anxiety and depression have been identified as major causes of lower levels of 
adherence to treatment recommendations (Addolorato et al., 1996) and poor adaptation to 
the disease (Ciacci, Iavarone, Mazzacca & De Rosa 1998).  There is also evidence from 
Swedish studies that women with CD score lower than the general population on 
subjective measures of general health and vitality (Hallert et al., 1998) and experience 
poorer quality of life than their male counterparts (Hallert et al., 2003).   
However, studies on the impact of a gluten-free diet (GFD) on HRQoL have 
produced conflicting results. For example, US-American (Green et al., 2001), Canadian 
(Zarkadas et al., 2006) and Swedish studies (Roos, Karner & Hallert, 2006) report an 
average HRQoL for adult celiac sufferers comparable with the general population; 
whereas studies conducted in Italy (Fera et al., 2003) Northern Ireland (O’Leary et al., 
2002) and Germany (Häuser et al., 2006) demonstrate a reduced HRQL compared with 
the general population or healthy controls. 
More research is needed to determine whether affective disorders and reduced 
quality of life are a feature of CD.  At present there is a dearth of studies about the 
psychosocial effects of CD in the UK population. Knowledge of the prevalence of 
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psychological distress in the UK coeliac population is important for clinical management, 
particularly as there is evidence from Italy that psychological counselling can improve 
adherence to a gluten-free diet in coeliac patients with affective disorder (Addolorato et 
al., 2004). A better understanding and greater knowledge of the psychosocial effects of 
CD on sufferers could enhance the clinical management of the condition and ultimately 
improve the quality of life for adults with the disease. 
The two important concepts of illness representation (Leventhal, Nerenz & Steele, 
1984; Petrie & Weinman, 1997), i.e. how people interpret current and potential health 
events or threats, and self-efficacy (Bandura, 1977; 1997), i.e. the belief that an 
individual has in his or her capability for managing a particular challenge, feature 
prominently in research concerning responses to and coping with chronic illness.  
However, at present there has been no investigation of these concepts in relation to CD. 
Knowledge of these is important for informing therapeutic interventions, to help in the 
clinical management of the disease.     
Although illness perceptions and self-efficacy have been independently constructed 
they have a common theme at their core.  Each posits that individuals’ personal 
constructs of their condition and of their ability to cope with that condition are at the 
basis of effective self-management (Lau-Walker, 2004).  In view of the fact that there is 
considerable overlap within the two theoretical concepts it seems likely that there will be 
a relationship between the components of the two models and more specifically that 
illness representations will be predictive of self-efficacy.  
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Aims 
The survey had three main aims:- 
1. To investigate gender differences in quality of life and sense of well-being in 
adults with CD in the UK 
2. To explore the illness perceptions and self-efficacy beliefs of adults with CD in 
the UK and their relationship with adherence to the gluten free diet. 
3. To explore the influence of individuals’ demographic characteristics and illness 
perceptions on self-efficacy, well-being, quality of life and adherence to the 
gluten free diet. 
 
Method 
Design and Procedure 
The study design was a cross-sectional postal questionnaire.  Adult members (aged 18 
years and over) of Coeliac UK (the national UK charity supporting people with CD) were 
invited to participate in a questionnaire survey designed to investigate the psychological 
and social effects of living with CD.   The survey was advertised in the quarterly Coeliac 
UK magazine and questionnaire packs were sent to those interested in participating. 
Some questionnaire packs were also distributed at local Coeliac UK support meetings.  
Members of Coeliac UK were approached because all members of the Society have been 
diagnosed with CD via a screening blood test and biopsy of the small intestine.  This was 
an attempt to ensure that those experiencing symptoms of CD, but who had no formal 
diagnosis were excluded from the study. 
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The survey pack included an information sheet, consent form, sociodemographic 
questionnaire and four validated measures described below. Ethical approval was 
obtained from the University of Birmingham, School of Psychology Research Ethics 
Committee.  
 
Participants 
The majority of participants were women (80%) and of White British origin (95%).  Men 
were significantly older than women (mean difference 8.61; Z= -4.08; P= <0.001).  
Adherence to a gluten free diet (GFD) was high with only 13% of participants reporting 
that they did not adhere all the time.  In general, the number of years since diagnosis 
corresponded with the duration of membership in Coeliac UK.  Over half the sample 
(57%) had received their diagnosis in their forties and fifties.  The majority of 
participants were well educated, married or co-habiting and had professional 
occupational status. Full sample characteristics are presented in Table 1.    
 
[Table 1 here] 
 
Measures 
Perceived Medical Condition Self-Management Scale 
A Coeliac Disease-specific adaptation of the Perceived Medical Condition Self-
Management Scale (PMCSMS) was used to assess the degree to which the participants 
felt competent or self-efficacious in managing their CD.  The PMCSMS is an 8-item 
measure based upon the Perceived Health Competence Scale (Smith, Wallston, & Smith, 
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1995).  It was developed as a template that could be made disease-specific and used with 
any medical condition requiring self-management. It has been successfully adapted for 
use with patients with diabetes and was found to be a reliable and valid measure 
(Wallston et al., 2007).  Coeliac disease specific questions include “I handle myself well 
in respect to my Coeliac Disease” and “no matter how hard I try, managing my Coeliac 
Disease doesn’t turn out the way I would like.” Responses are rated on a 5-point Likert 
scale from ‘strongly disagree’ to ‘strongly agree’. Higher scores indicate stronger 
perceptions of self-efficacy.   
 
The Revised Illness Perception Questionnaire (IPQ-R) 
The original Illness Perception Questionnaire (Weinman, Petrie, Moss-Morris & Horne, 
1996) was developed to provide a quantitative assessment of the five components 
(identity, consequences, timeline, control/cure and cause) of illness representation in 
Leventhal’s Self-Regulatory Model (Leventhal et al., 1984; 1997). The revised version 
(IPQ-R) includes a new subscale relating to emotional representations and divides control 
beliefs into personal attempts to control illness and control of illness by treatment.  It has 
demonstrated sound reliability, discriminant and predictive validity (Moss-Morris et al., 
2002).   
 
General Well-being Index (GWBI) 
The Psychological General Well-Being Index originally developed in the US by Harold 
Dupuy (1984) was adapted for use in Britain by Hunt & McKenna (1992) and renamed 
the General Well-Being Index (GWBI).  It provides a self-report of intrapersonal 
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affective states that reflect subjective well-being or distress.  The index consists of 
questions that cover six affective states: anxiety, depressed mood, feelings of positive 
well-being, self-control, general health and vitality.  The adapted measure has been 
shown to have good psychometric properties while being short, easy to use and 
acceptable to participants (Hunt & McKenna, 1992). Responses are rated on a 5-point 
Likert scale from ‘strongly disagree’ to ‘strongly agree’. The approach adopted in this 
study was to score the items so that higher scores indicated better psychological well-
being. 
 
The Coeliac Disease Questionnaire (CDQ) 
The Coeliac Disease Questionnaire (CDQ) is a reliable and valid disease specific 
instrument for measuring health-related quality of life in adult patients with CD (Hauser 
et al., 2007).  Recently developed in Germany the index has been translated into English.  
The CDQ comprises four subscales: gastrointestinal symptoms, emotional well-being, 
social restrictions and disease-related worries.  Responses are rated on a 7-point scale 
from ‘strongly disagree’ to ‘strongly agree’. High scores indicate a good HRQoL.   
 
Adherence 
Adherence to the gluten-free diet was measured by one question on a 5-point Likert scale 
asking participants to rate in general how strictly they maintained their diet. 
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Data Analysis 
The data were analysed using the Statistical Package for the Social Sciences (SPSS 15 for 
Windows). Reliability analyses were carried out on the four questionnaires using 
Cronbach’s alpha (presented in Table 2). These indicated a high level of internal 
consistency for all the measures except four subscales belonging to the IPQ-R, namely: 
Timeline (acute/chronic); Treatment Control; Risk and Immunity.  These subscales were 
removed from subsequent analyses.   
With the exception of the adherence scores, the data were found to be reasonably 
normally distributed and this was confirmed by the Kolmogorov-Smirnov test.  Therefore 
parametric analysis was chosen, except when addressing adherence, where non-
parametric analysis was used. To allow comparisons with the results of other studies both 
medians and means are presented.  Preliminary descriptive and univariate procedures 
were employed before bivariate tests of association (Pearson’s) or difference (t-tests) 
were carried out.  Backward stepwise multiple regression analysis was used to investigate 
the predictive strength of a range of variables on well being, quality of life and self 
efficacy. Logistic regression was used to look at the influence of a range of variables on 
adherence.  
 
Table 2 [here] 
  
 The dependent variable adherence was split at the median due to its distribution.   
Up to 25% of missing items on the PMCSMS, IPQ-R, GWBI and CDQ were replaced by 
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the median of the items of the respective sub-scale.  If more than 25% of the items of a 
subscale were missing the respective measure was excluded from further analysis.   
 
Results 
Two hundred and eighty eight out of 433 (66%) questionnaires were received back from 
participating members of Coeliac UK.  Four datasets had to be excluded as they were not 
accompanied by consent forms.  A number of questionnaires were excluded as there were 
more than 25% missing items as follows:- GWBI 10, CDQ 8, IPQ-R 6 and PMCSM 4.  
In total, 14 participants were excluded from the main analyses. 
 
Self-Efficacy 
The mean scores for the total sample (31.7 s.d. 5.9, range 14-40) indicated a relatively 
high level of perceived self-efficacy.   There was a significant difference in scores 
between the adherence groups.  As predicted, those in the lower group had weaker 
perceptions of their own self-efficacy to manage their CD (Z= -2.0; P=0.04). Conversely, 
those in the higher adherence group had stronger beliefs in their ability to manage their 
condition.   There was no difference in the level of perceived self-efficacy to manage 
their Coeliac Disease between men (mean= 32.2) and women (mean= 31.6).   
 
Psychological Well-being                           
The distribution of GWBI scores for the whole sample ranged from 29 to 110 with a 
mean of 79.0 (s.d. 15.4) out of a possible top score of 110.  Men tended to score slightly 
higher than women indicating better psychological well-being.  These differences were 
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significant for the total score and the following subscales: Anxiety, Depressed Mood and 
Self-Control.  There was no significance in GWBI scores between adherence groups (Z= 
-0.30; P=0.76). 
    
Health Related Quality of Life (HRQoL) 
The distribution of Coeliac Disease Questionnaire scores for the whole sample ranged 
from 61 to 194 with a mean of 152.2 (s.d. 26.4) out of a possible top score of 196  
reflecting reduced HRQoL. Reduced HRQoL was defined by scores ≤ 10% percentile of 
the total CDQ score.  Men tended to score slightly higher on the CDQ than women, but 
the differences were only significant for the total scores and two sub-scales: Emotion and 
Social.  There was no significant difference in CDQ total score and adherence group (Z= 
-1.25; P=0.20). 
 
Illness Perceptions 
Mean scores for consequences (3.5, s.d. 0.82), personal control (4.3, s.d. 0.67) and illness 
coherence (4.2, s.d. 0.82) were high, reflecting a coherent understanding of CD, strong 
perceptions of personal ability to control it and strong beliefs about the serious 
consequences of CD.  Participants did not attribute many symptoms to their CD, 
reflecting a low disease identity (mean 3.3, s.d.2.94). The most important cause identified 
by participants was genetic risk with over half (52.2%) attributing the development of 
their condition to their genes.  Table 3 shows the mean and median scores for each of the 
included IPQ-R subscales for men and women and differences between them. The results 
indicate that women had a significantly higher emotional response to their condition than 
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men.  Women also had significantly stronger beliefs that their CD was caused by 
psychological factors such as stress and mental attitude; however, there were no gender 
differences on the other dimensions.   
 
  [Table 3 – here] 
 
Associations Between Illness Perceptions and Distress 
Table 4 shows Pearson’s r correlations between illness perceptions, age and self efficacy, 
measures of well-being and HRQoL for the whole sample. The majority of the 
coefficients are modest, lying between 0.40 - 0.65.  Those lying between 0.19 – 0.39 are 
considered low (Cohen & Holliday, 1982).  The lower the disease identity of participants 
the higher their self-efficacy, HRQoL and general well-being scores were.  The weaker 
the beliefs of participants in the severity of their CD, the higher their self-efficacy, 
HRQoL and psychological well-being scores were.  Stronger perceptions of personal 
control over the condition and a clearer understanding of CD were also associated with 
increased self-efficacy and improved HRQoL.  The weaker participants’ beliefs that CD 
was variable over time and the lower their emotional responses were to CD the higher 
their self-efficacy, HRQoL and psychological well-being scores were.   Total scores for 
the CDQ and GWBI were also strongly correlated (Pearson 0.77, P=0.01).   
 
[Table 4 – here] 
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Predicting General Well-being, HRQoL and Self-Efficacy 
The results of backward stepwise multiple regression analyses to investigate predictors of 
general well-being, HRQoL and self-efficacy were conducted.  A number of variables 
were entered for each of these analyses, i.e. gender, age at diagnosis, years since 
diagnosis, all the subscales of the IPQ and adherence but those which did not 
significantly contribute to the variance in the outcome variables were systematically 
eliminated from the models. In all cases, models were produced which found that a 
number of variables, in combination, explained a significant degree of variation in the 
outcomes.  
 
In relation to well-being (GWBI total): Adjusted R square = .401; F4,261 = 45.43, 
p<0.0001 (using the backwards stepwise method). Contributing variables were: Age at 
diagnosis, Identity, Timeline cyclical and Emotional representations. In relation to Health 
Related Quality of Life (CDQ total): Adjusted R square = .629; F6,262 = 76.63, p<0.0001 
(using the backwards stepwise method). Contributing variables were: Age at diagnosis, 
Identity, Consequences, Illness Coherence, Timeline cyclical and Emotional 
representations. Finally, in relation to self-efficacy (PMCSMStotal): Adjusted R square = 
.554; F6,264 = 56.96, p<0.0001 (using the backwards stepwise method). Contributing 
variables were: Age at diagnosis, Personal Control, Consequences, Illness Coherence, 
Timeline cyclical and Emotional representations. 
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Predictors of GFD adherence 
Table 5 shows the results of a binary logistic regression analysis to predict high 
adherence to a gluten-free diet (GFD). Variables entered in to this regression were age, 
all illness perception subscales, self-efficacy, well-being and health-related quality of life. 
The most predictive independent variables were older age, strong beliefs in the serious 
consequences and weak beliefs in the cyclical nature of CD (or conversely beliefs in the 
chronicity of the condition).  This means that the older participants were and the stronger 
their beliefs in the seriousness of CD the more likely they were to stick to a GFD.  
Furthermore, the weaker participants’ beliefs in the cyclical nature of CD the more likely 
they were to adhere to a GFD.  The correct classification rate for the model was 86%.  
None of the outcome measures, self-efficacy, general well-being and HRQoL were strong 
predictors of high adherence.   
 The internal validity of this model was good.  In the omnibus test the coefficients 
were significant (P= <0.0001) and the significance level in the Hosmer-Lemeshov 
(Goodness of fit) test was 0.86, above the predefined P-value of 0.05, thus confirming 
goodness of fit.   
 
  [Table 5 – here]      
   
 
Discussion 
This study investigated the psychosocial impact of CD on a UK adult population in terms 
of health-related quality of life and psychological well-being. It is also the first to 
investigate the illness perceptions of individuals with CD.   
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HRQoL, Psychological Well-being and Self-Efficacy 
The results for HRQoL are in line with previous research which indicates that lower 
quality of life affects individuals with CD.  The mean and total distribution of scores for 
the CDQ were comparable with those found in the German Coeliac Society population by 
the authors of the instrument (Häuser et al., 2007).  In this German study to validate the 
CDQ the mean score for participants (n=516) who belonged to the German Coeliac 
Society was 151.1 (s.d. 25.2).  Reduced HRQoL was defined by scores ≤ 10% percentile 
of the total CDQ score which was 11% of the sample.  There were significant differences 
between men and women for all sub-scales, reflecting better health related quality of life 
for men. In the current UK population, the univariate analyses showed that men had 
higher scores than women on the total scale and two subscales, Emotion and Social.  This 
indicates that women were more emotionally affected by their CD than men and found 
the condition more socially restrictive.  However, it could not be demonstrated by 
multivariate analysis that there was an association between male gender and increased 
HRQoL. 
For psychological well-being the results were similar in that GWBI scores indicated 
a reduced overall level of psychological well-being.  The mean GWBI of this CD 
population was slightly lower compared to individuals with long-term health problems 
drawn from a UK primary care population and considerably lower when compared to a 
healthy sub-set drawn from the same sample (Hopton, Hunt, Shiels & Smith, 1995).  In 
this UK sample the distribution of GWBI scores ranged from 29 to 109 with a mean of 
82.2 (s.d. 14.6).  Forty five percent of patients had a limiting long-term illness, health 
problem or handicap In a healthy sub-group of this sample i.e. those with no long-
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standing illness and absence of anxiety and depression, GWBI scores ranged from 54 to 
109 with a mean of 94.0 (s.d. 10.9).   In the CD sample, there were also slight differences 
between the mean scores of men and women on this measure for total score, and the 
subscales of anxiety, depressed mood and self-control, with men having a better outcome.  
Once again however, gender difference was not demonstrated in the multivariate 
analysis. 
The mean PMCSMS scores showed a relatively high level of perceived self-
efficacy in this CD population meaning that individuals generally felt confident with 
managing their condition.  Those in the lower adherence group had significantly reduced 
self-efficacy compared with those in the high adherence group.  This is in line with early 
diabetes research that found patients adhering to dietary advice were more likely to report 
feeling competent to self-manage their diabetes (Talbot et al., 1997).  However, the 
PMCSMS was not found to predict adherence in the multivariate analysis.  Furthermore, 
no significant difference was found between the scores of men and women unlike the 
findings in a recent study of people with Diabetes where men scored higher than women 
(Wallston et al., 2007).   
 
Illness Perceptions 
In general the participants reported a coherent understanding of their condition with 
strong perceptions of their personal ability to control it and strong beliefs about the 
serious consequences of CD. Few differences in illness perceptions were identified 
between men and women. The finding that women were more likely to respond more 
emotionally to their CD than men may be a reflection of different ways of coping 
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between men and women (Hallert et al., 2002).  Women also believed more strongly than 
men that psychological causes such as stress had some bearing on the development of 
their condition. Again, this is perhaps a reflection of differences in western society at 
large in which women tend to report more psychological symptoms than men (Wittchen, 
2002).  
There were associations between weak identity perceptions and increased HRQoL 
and enhanced general well-being.  Weak beliefs in the serious consequences of CD 
increased the likelihood of increased self-efficacy and HRQoL.  Strong perceived 
personal control increased the probability of a higher self-efficacy score.  Strong 
perceived illness coherence tended to increase the likelihood of better self-efficacy and 
HRQoL.  A reduced emotional response to CD and weak beliefs that the condition was 
cyclical in nature increased the probability of better self-efficacy, good HRQoL and 
enhanced psychological well-being. At present there exist no similar studies investigating 
the illness perceptions of individuals with CD so that comparisons cannot be made.  
However, in a study focusing on illness representations and outcomes in irritable bowel 
syndrome (Rutter & Rutter, 2002) the authors found similarly that the reporting of serious 
perceived consequences was associated with reduced quality of life and poorer scores for 
anxiety and depression.   The high correlation between CDQ and GWBI scores suggest a 
close relationship between psychological well-being and HRQoL. 
 
Adherence 
The adherence rate was high with 87% of participants reporting that they stuck to a GFD 
all of the time, the remaining 13% reported that they adhered most or some of the time.  
 19 
The small numbers of participants showing low adherence to the diet make the analysis 
of adherence less robust. 
 
Predictors of Psychological Well-being, HRQoL, Self-efficacy and Adherence 
In the regression analyses, the only consistent predictor of all four outcome measures was 
Timeline cyclical. In all cases, weaker beliefs in the cyclical nature of CD were related to 
better outcome. Age at diagnosis, perceived consequences and emotional responses also 
played an influential role in a number of outcomes.  Being older at diagnosis, holding 
weaker beliefs in the serious consequences of CD and reduced emotional responses were 
more likely to be associated with better health-related quality of life and self-efficacy; 
whilst being older at diagnosis and having a less intense emotional response was also 
associated with better well-being. Older age had a significant influence on adherence and 
enhanced psychological well-being. A weaker CD identity was more likely to be 
associated with an improved HRQoL.  Greater perceived illness coherence also increased 
the likelihood of a better HRQoL and higher self-efficacy.  Stronger beliefs in personal 
control were associated with increased self-efficacy.  
Although strong beliefs in serious consequences was a likely predictor of 
adherence, results reported in the paragraph above indicated that weaker beliefs in serious 
consequences increased the likelihood of enhanced psychological well-being, HRQoL 
and Self-efficacy.  However, there was no evidence in this study to suggest that those in 
the high adherence group had poorer scores than the low adherence group on any of these 
outcome measures.  This interaction effect needs further investigation in future research.  
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Limitations of the Study 
Some limitations of the study should be born in mind. The participants were recruited 
from adult members of Coeliac UK leading to a possible selection bias.  Although the 
sample represented a small proportion of adult members of Coeliac UK they were 
representative of the profile of the Charity’s membership, i.e. predominantly white 
Caucasian and of high educational level. Due to this profile the results may not generalise 
to people with CD of lower educational level or ethnic groups whose beliefs about CD 
and illness perceptions may differ.  Further, there is evidence that membership of a self-
help organization is predictive of reduced life satisfaction (Janke, Klump, Gregor & 
Häuser, 2005).  However, there are no comparative data available between individuals 
with CD with and without membership of Coeliac UK.  It is possible that there is a 
further response bias from individuals with reduced psychological well-being and 
HRQoL being more likely to return the questionnaires.  Therefore, it seems unlikely that 
the findings of the study are representative of the UK general population of people with 
coeliac disease.  Conversely this group of individuals is the only available large UK 
sample studied to date.  
The cross-sectional nature of this study should also be considered, since this 
means that the results show only associations between variables and prohibit conclusions 
being drawn about causality.   The inclusion of a control group or healthy non-CD group 
would have facilitated the interpretation of scores for HRQoL and psychological well-
being by providing normative data.  Measuring adherence to a gluten-free diet can be 
challenging, particularly when using a self report measure.  Measurement of adherence 
may have been enhanced with the addition of recent coeliac antibody blood test results.  
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However, this is not always an accurate measure of adherence.  Further research should 
consider a series of adherence measures in order to gain an accurate measure of dietary 
self-management.  Finally, it should also be mentioned that the data are self-reported 
which may bias the answers to sensitive questions such as dietary compliance.  However, 
anonymity of the data was maintained to help minimize this potential bias.  
 
Conclusions 
Amongst adult members of Coeliac UK there was evidence of reduced HRQoL and 
decreased psychological well-being.  The gender differences in quality of life found in 
previous research were not repeated in the multivariate analyses used in this study.  More 
research is needed in the UK Coeliac Disease population using robust methodologies 
such as case control or longitudinal studies to investigate this potential difference further.   
Further investigation is also required into possible differences in quality of life and 
well-being between those who adhere to a GFD and those who do not.  Self-efficacy and 
illness perceptions appeared to be influential factors in this study and could play a role in 
informing psycho-education for individuals who might benefit from therapeutic 
intervention to improve GFD adherence and enhance psychological well-being.  More 
information is needed on the link between self-efficacy, illness perceptions and adherence 
to a GFD.  Further knowledge of these factors is important for informing therapeutic 
interventions, to help in the clinical management of Coeliac Disease. 
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Table 1 Sociodemographic Characteristics of Study Sample (n=284) 
Variable Number (%) Mean (SD) Range Median 25th – 75
th
 
Percentile 
Sex (female)                                                 
Age All                                                         
      Male  
      Female                                                   
Duration of membership in Coeliac UK 
      <1-5 yrs                                                  
      6-20 yrs                                                  
       >20 yrs                                                  
Years since diagnosis 
     <1-5 yrs                                                   
     6-20 yrs                                                   
     21-40+ yrs                                               
Age at diagnosis 
     <1-20 yrs                                                 
     21-40 yrs                                                 
     41-50+ yrs                                               
Adherence to a GFD 
     All of the time                                         
     Most/some of the time                            
Marital status 
     Married 
     Co-habiting                                
     Separated/divorced/widowed                  
     Single (never married)                             
Highest educational level 
     No qualifications                                      
     Secondary School                                     
     Vocational training                                   
     University degree                                    
Occupational status (previous or current) 
     Professional                                             
     Managerial/technical                               
     Non-manual skilled                                 
     Manual skilled/partly skilled                   
     Non-skilled/home-maker                         
 
227    (80.0) 
 
 
 
133   (46.8)                            
103   (36.3)                                                                    
48     (16.9) 
                                                
127  (44.7)                                  
103  (36.3)                                
53    (18.6) 
                                   
34   (12.1)                             
85   (30.1)                                
163 (57.8) 
                                       
246 (86.6)                                    
37   (13.4) 
 
184 (64.8) 
26  (9.2)                                                                                                                            
36   (12.8) 
  -                                
36    (12.8)                                  
63    (22.3) 
67    (23.6)                     
116  (40.8) 
                                           
137  (48.9)                                     
71    (25.4) 
21    (7.4)                     
24    (9.0)   
27    (9.7) 
 
 
54.0 (14.6) 
61.0 (13.6)   
52.3 (14.4)               
 
 
19-85 
23-85 
19-84 
 
 
56 
63 
54 
 
44-65 
53-70 
43-63 
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Table 2 Reliability coefficients for subscales of all measures 
Measure and 
Sub-scale 
Number of 
items 
Cronbach’s 
alpha 
PMCSMS 
      Total Scale                                                           
 
IPQ-R 
     Identity                                            
     Timeline (acute/chronic)                  
     Consequences                                   
     Personal control                                
     Treatment control  
     Illness coherence                                                                                                   
     Timeline (cyclical)                           
     Emotional representations               
     Psychological causes                       
     Risk                                                 
     Immunity                                         
 
GWBI 
     Positive well-being                         
     General health                                 
     Depressed mood                              
     Anxiety                                            
     Self-control                                      
     Vitality                                             
 
CDQ 
     Gastrointestinal symptoms                                    
     Emotional well-being                      
     Social restrictions                            
     Disease related worries                    
 
8 
 
 
14 
6 
6                                                                                                          
6                                                              
5                                                                  
5
4                                                                    
6                                                                 
6                                                                
6                                                               
3 
 
 
4                                                                   
3                                                              
3                                                               
5                                                                
3                                                                
4 
 
                                          
7                                                       
7                                                                   
7                                                                    
7                           
 
0.92 
 
                                                                                 
0.80                                                                    
0.51*                                                             
0.79
0.81                           
0.51*                         
0.90                          
0.92                     
0.88                        
0.87                         
0.67*                            
0.42* 
 
 
0.86                   
0.86                        
0.91                       
0.85                      
0.88                      
0.87 
 
                                  
0.82                          
0.91                   
0.85                         
0.81      
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Table 3 Mean and Median Scores for Illness Perceptions 
 
  IPQ-R                             Means (standard deviations) and Medians (ranges) 
Subscale                                 Females (n=219)                Males (n=55)               Difference test 
Identity 
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional responses 
 
3.5 (3.02) 
3.5 (0.82) 
4.3 (0.62) 
4.2 (0.79) 
2.3 (1.10) 
2.6 (0.96) 
 
3.0  (1-12) 
3.6 (1.3-4.8) 
4.5 (2.1-5.0) 
4.4 (1.8-5.0) 
2.0 (1.0-5.0) 
2.5 (1.0-5.0) 
 
2.9 (2.58) 
3.5 (0.80) 
4.2 (0.84) 
4.2 (0.95) 
2.0 (0.99) 
2.2 (0.98) 
 
3.0  (1-12) 
3.6 (1.6-5.0) 
4.3 (1.0-5.0) 
5.6 (1.0-5.0) 
2.0 (1.0-4.5) 
2.0 (1.0-5.0) 
t=-1.12  p= .26 
t=  0.29  p= .77 
t= -1.28 p = .20 
t= -.37   p=. 72 
t= -1.44 p= .15 
t=-2.68  p= .008* 
Note: *= significant difference 
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  Table 4 Correlations (Pearson) between age and Illness Perceptions, and Outcome 
Measures  
Total Scores n= 274 
                                                PMCSMS                CDQ                    GWBI 
Age 
Identity 
Consequences 
Personal Control 
Illness Coherence 
Timeline cyclical 
Emotional representations 
 0.21
**
 
-0.33
**
 
-0.43
**
 
 0.37
** 
 0.55
**
 
-0.50
** 
-0.62
** 
 
 0.28
** 
-0.58
**
 
-0.53
**
 
 0.21
** 
 0.41
** 
-0.57
** 
-0.66
**
 
 0.25
* 
-0.44
**
 
-0.37
** 
 0.08 
 0.29
**
 
-0.49
** 
-0.53
* 
 
   Note: *p = 0.01, **p ≤0.001                                                                                                                 
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  Table 5  Logistic regression analysis of factors predicting high adherence to a GFD 
 
 Independent                                  Odds 
   Variables                                    Ratio               95% CI                B               P-value 
Age 
PMCSMS 
GBWI 
CDQ  
Identity  
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional representations                     
1.04 
1.07 
0.97 
0.99 
0.96 
1.15 
1.08 
1.01 
0.87 
0.94
1.01-1.07 
0.97-1.17 
0.93-1.02 
0.96-1.02 
0.81-1.13 
1.03-1.28 
0.96-1.20 
0.90-1.13 
0.77-0.98 
0.85-1.05 
 0.04 
 0.07   
-0.03 
-0.01 
-0.03 
 0.14 
 0.07 
 0.01 
-0.14 
-0.05 
0.002 
0.14 
0.17 
0.54 
0.65 
  0.009 
0.16 
0.83 
0.02 
0.31 
 
